Wegovy 1.7 mg FlexTouch
  1. Home
  2. Wegovy
  3. Wegovy 1.7 mg FlexTouch

Wegovy 1.7 mg FlexTouch

Wegovy 1.7 mg FlexTouch is a prescription GLP-1 receptor agonist prefilled injection pen used for chronic weight management in adults and eligible adolescents when combined with a reduced-calorie diet and increased physical activity. It delivers 1.7 mg of semaglutide by subcutaneous injection and is commonly used during the dose-escalation phase of treatment. The ergonomic FlexTouch pen provides convenient, accurate, and reliable dose administration.

BUY NOW

Category

Wegovy 1.7 mg FlexTouch contains semaglutide, a GLP-1 receptor agonist that helps reduce body weight by regulating appetite, increasing satiety, slowing gastric emptying, and decreasing calorie intake. The 1.7 mg strength is typically prescribed as an intermediate dose during the recommended dose-escalation schedule before reaching the maintenance dose when clinically appropriate. Manufactured under stringent pharmaceutical quality standards, the sterile prefilled FlexTouch pen is designed for precise subcutaneous administration and dependable clinical performance. Wegovy 1.7 mg FlexTouch should be used only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Wegovy 1.7 mg FlexTouch
Active Ingredient Semaglutide
Strength 1.7 mg
Dosage Form Prefilled Injection Pen
Route of Administration Subcutaneous Injection
Storage Refrigerate at 2°C–8°C before first use

Product Also Known As

Wegovy 1.7 mg FlexTouch, Wegovy FlexTouch Pen, Semaglutide 1.7 mg Pen, Wegovy Prefilled Pen, GLP-1 Weight Loss Pen, Weekly Semaglutide Injection Pen, Semaglutide Injectable Pen